Differential metabolic responses to pluronic in MDR and non-MDR cells: A novel pathway for chemosensitization of drug resistant cancers-Reference-Cited by-同舟云学术

Differential metabolic responses to pluronic in MDR and non-MDR cells: A novel pathway for chemosensitization of drug resistant cancers

Published:2010-02 Issue:1 Volume:142 Page:89-100
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Alakhova Daria Yu.,Rapoport Nataliya Y.,Batrakova Elena V.,Timoshin Alexander A.,Li Shu,Nicholls David,Alakhov Valery Yu.,Kabanov Alexander V.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference39 articles.

1. Multidrug resistance in cancer: role of ATP-dependent transporters;Gottesman;Nat. Rev., Cancer,2002

2. Characterization of a novel metabolic strategy used by drug-resistant tumor cells;Harper;FASEB J.,2002

3. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion;Batrakova;Br. J. Cancer,2001

4. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer;Alakhov;Bioconjug. Chem.,1996

5. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells;Venne;Cancer Res.,1996

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibiting Multidrug Resistance with Transferrin-Targeted Polymersomes through Optimization of Ligand Density;Langmuir;2023-11-03

2. Nanodelivery systems: An efficient and target‐specific approach for drug‐resistant cancers;Cancer Medicine;2023-09

3. Theranostics for Triple-Negative Breast Cancer;Diagnostics;2023-01-11

4. Novel Non-Viral Vectors Based on Pluronic® F68PEI with Application in Oncology Field;Polymers;2022-12-05

5. Metabolic Signatures of Surface-Modified Poly(lactic-co-glycolic acid) Nanoparticles in Differentiated THP-1 Cells Derived with Liquid Chromatography-Mass Spectrometry-based Metabolomics;ACS Omega;2022-08-12